EBV antibodies

When EBV Antibodies Tell Different Stories

Your body produces different types of antibodies at various stages of EBV infection, creating a pattern that helps doctors understand your infection timeline. The three main antibodies tested each have their own story to tell.

VCA IgM antibodies are your body's first responders to EBV infection. These antibodies appear when you're first infected with EBV and usually disappear in 4 to 6 weeks. Finding VCA IgM antibodies typically indicates you currently have or recently had an active EBV infection. These are the antibodies most associated with the acute phase of glandular fever.

VCA IgG antibodies represent your body's long-term memory of EBV infection. Anti-VCA IgG appears in the acute phase of EBV infection, peaks at 2 to 4 weeks after onset, declines slightly then persists for the rest of a person's life. These antibodies indicate that you have been exposed to EBV at some point, but don't tell us exactly when.

EBNA IgG antibodies are the late arrivals that confirm past infection. A positive EBNA IgG result indicates infection more than six weeks previously. A positive result indicates PAST infection and excludes primary infection. These antibodies typically develop several weeks to months after initial infection and persist for life.

The pattern of these antibodies together creates a clear picture: current infection shows VCA IgM and VCA IgG positive with EBNA IgG negative, whilst past infection shows VCA IgG and EBNA IgG positive with VCA IgM negative.

When EBV Antibodies Tell Different Stories

Your body produces different types of antibodies at various stages of EBV infection, creating a pattern that helps doctors understand your infection timeline. The three main antibodies tested each have their own story to tell.

VCA IgM antibodies are your body's first responders to EBV infection. These antibodies appear when you're first infected with EBV and usually disappear in 4 to 6 weeks. Finding VCA IgM antibodies typically indicates you currently have or recently had an active EBV infection. These are the antibodies most associated with the acute phase of glandular fever.

VCA IgG antibodies represent your body's long-term memory of EBV infection. Anti-VCA IgG appears in the acute phase of EBV infection, peaks at 2 to 4 weeks after onset, declines slightly then persists for the rest of a person's life. These antibodies indicate that you have been exposed to EBV at some point, but don't tell us exactly when.

EBNA IgG antibodies are the late arrivals that confirm past infection. A positive EBNA IgG result indicates infection more than six weeks previously. A positive result indicates PAST infection and excludes primary infection. These antibodies typically develop several weeks to months after initial infection and persist for life.

The pattern of these antibodies together creates a clear picture: current infection shows VCA IgM and VCA IgG positive with EBNA IgG negative, whilst past infection shows VCA IgG and EBNA IgG positive with VCA IgM negative.

When EBV Antibodies Tell Different Stories

Your body produces different types of antibodies at various stages of EBV infection, creating a pattern that helps doctors understand your infection timeline. The three main antibodies tested each have their own story to tell.

VCA IgM antibodies are your body's first responders to EBV infection. These antibodies appear when you're first infected with EBV and usually disappear in 4 to 6 weeks. Finding VCA IgM antibodies typically indicates you currently have or recently had an active EBV infection. These are the antibodies most associated with the acute phase of glandular fever.

VCA IgG antibodies represent your body's long-term memory of EBV infection. Anti-VCA IgG appears in the acute phase of EBV infection, peaks at 2 to 4 weeks after onset, declines slightly then persists for the rest of a person's life. These antibodies indicate that you have been exposed to EBV at some point, but don't tell us exactly when.

EBNA IgG antibodies are the late arrivals that confirm past infection. A positive EBNA IgG result indicates infection more than six weeks previously. A positive result indicates PAST infection and excludes primary infection. These antibodies typically develop several weeks to months after initial infection and persist for life.

The pattern of these antibodies together creates a clear picture: current infection shows VCA IgM and VCA IgG positive with EBNA IgG negative, whilst past infection shows VCA IgG and EBNA IgG positive with VCA IgM negative.

When EBV Antibodies Tell Different Stories

Your body produces different types of antibodies at various stages of EBV infection, creating a pattern that helps doctors understand your infection timeline. The three main antibodies tested each have their own story to tell.

VCA IgM antibodies are your body's first responders to EBV infection. These antibodies appear when you're first infected with EBV and usually disappear in 4 to 6 weeks. Finding VCA IgM antibodies typically indicates you currently have or recently had an active EBV infection. These are the antibodies most associated with the acute phase of glandular fever.

VCA IgG antibodies represent your body's long-term memory of EBV infection. Anti-VCA IgG appears in the acute phase of EBV infection, peaks at 2 to 4 weeks after onset, declines slightly then persists for the rest of a person's life. These antibodies indicate that you have been exposed to EBV at some point, but don't tell us exactly when.

EBNA IgG antibodies are the late arrivals that confirm past infection. A positive EBNA IgG result indicates infection more than six weeks previously. A positive result indicates PAST infection and excludes primary infection. These antibodies typically develop several weeks to months after initial infection and persist for life.

The pattern of these antibodies together creates a clear picture: current infection shows VCA IgM and VCA IgG positive with EBNA IgG negative, whilst past infection shows VCA IgG and EBNA IgG positive with VCA IgM negative.

What Influences Your EBV Antibody Levels

The timing of EBV antibody development follows a predictable pattern, but individual variations can affect test results. The most important factor is the stage of infection when testing occurs. Very early in infection, some antibodies may not yet be detectable, whilst others may take weeks or months to appear.

Your age when first infected can influence the severity of symptoms and antibody response. When the infection occurs in adolescents or adults it causes glandular fever in up to half of those infected, whilst children often have milder symptoms or no symptoms at all. However, antibody production typically follows similar patterns regardless of age.

Your overall immune system health can affect antibody production. People with compromised immune systems may produce lower levels of antibodies or experience delayed responses, potentially affecting test interpretation. Additionally, some individuals may not develop all expected antibodies—approximately 5% to 10% of patients with EBV never develop certain antibodies even after proven infection.

The timing between infection and testing is crucial for accurate interpretation. Early in the course of clinical presentation, VCA IgM antibodies may not necessarily be present, which means very early testing might miss an active infection. Similarly, EBNA antibodies may take several months to develop, so their absence doesn't rule out recent infection.

What Influences Your EBV Antibody Levels

The timing of EBV antibody development follows a predictable pattern, but individual variations can affect test results. The most important factor is the stage of infection when testing occurs. Very early in infection, some antibodies may not yet be detectable, whilst others may take weeks or months to appear.

Your age when first infected can influence the severity of symptoms and antibody response. When the infection occurs in adolescents or adults it causes glandular fever in up to half of those infected, whilst children often have milder symptoms or no symptoms at all. However, antibody production typically follows similar patterns regardless of age.

Your overall immune system health can affect antibody production. People with compromised immune systems may produce lower levels of antibodies or experience delayed responses, potentially affecting test interpretation. Additionally, some individuals may not develop all expected antibodies—approximately 5% to 10% of patients with EBV never develop certain antibodies even after proven infection.

The timing between infection and testing is crucial for accurate interpretation. Early in the course of clinical presentation, VCA IgM antibodies may not necessarily be present, which means very early testing might miss an active infection. Similarly, EBNA antibodies may take several months to develop, so their absence doesn't rule out recent infection.

What Influences Your EBV Antibody Levels

The timing of EBV antibody development follows a predictable pattern, but individual variations can affect test results. The most important factor is the stage of infection when testing occurs. Very early in infection, some antibodies may not yet be detectable, whilst others may take weeks or months to appear.

Your age when first infected can influence the severity of symptoms and antibody response. When the infection occurs in adolescents or adults it causes glandular fever in up to half of those infected, whilst children often have milder symptoms or no symptoms at all. However, antibody production typically follows similar patterns regardless of age.

Your overall immune system health can affect antibody production. People with compromised immune systems may produce lower levels of antibodies or experience delayed responses, potentially affecting test interpretation. Additionally, some individuals may not develop all expected antibodies—approximately 5% to 10% of patients with EBV never develop certain antibodies even after proven infection.

The timing between infection and testing is crucial for accurate interpretation. Early in the course of clinical presentation, VCA IgM antibodies may not necessarily be present, which means very early testing might miss an active infection. Similarly, EBNA antibodies may take several months to develop, so their absence doesn't rule out recent infection.

What Influences Your EBV Antibody Levels

The timing of EBV antibody development follows a predictable pattern, but individual variations can affect test results. The most important factor is the stage of infection when testing occurs. Very early in infection, some antibodies may not yet be detectable, whilst others may take weeks or months to appear.

Your age when first infected can influence the severity of symptoms and antibody response. When the infection occurs in adolescents or adults it causes glandular fever in up to half of those infected, whilst children often have milder symptoms or no symptoms at all. However, antibody production typically follows similar patterns regardless of age.

Your overall immune system health can affect antibody production. People with compromised immune systems may produce lower levels of antibodies or experience delayed responses, potentially affecting test interpretation. Additionally, some individuals may not develop all expected antibodies—approximately 5% to 10% of patients with EBV never develop certain antibodies even after proven infection.

The timing between infection and testing is crucial for accurate interpretation. Early in the course of clinical presentation, VCA IgM antibodies may not necessarily be present, which means very early testing might miss an active infection. Similarly, EBNA antibodies may take several months to develop, so their absence doesn't rule out recent infection.

Who Should Be Tested for EBV Antibodies

EBV antibody testing is most commonly recommended when you have symptoms that could indicate glandular fever or infectious mononucleosis. A GP may order a blood test to confirm if you have glandular fever and to rule out other illnesses alongside other symptoms.

The classic symptoms that might prompt EBV testing include persistent fatigue, fever, sore throat, swollen lymph nodes, and sometimes an enlarged spleen. Symptoms include tiredness, fever, sore throat, swollen lymph nodes, an enlarged spleen and sometimes an enlarged liver. These symptoms can last for weeks or months, distinguishing glandular fever from simpler viral infections.

Testing might also be recommended if you have unexplained fatigue or illness that could be related to EBV, particularly if other common causes have been ruled out. Some people develop prolonged symptoms following EBV infection, and testing can help confirm whether EBV was the cause.

Who Should Be Tested for EBV Antibodies

EBV antibody testing is most commonly recommended when you have symptoms that could indicate glandular fever or infectious mononucleosis. A GP may order a blood test to confirm if you have glandular fever and to rule out other illnesses alongside other symptoms.

The classic symptoms that might prompt EBV testing include persistent fatigue, fever, sore throat, swollen lymph nodes, and sometimes an enlarged spleen. Symptoms include tiredness, fever, sore throat, swollen lymph nodes, an enlarged spleen and sometimes an enlarged liver. These symptoms can last for weeks or months, distinguishing glandular fever from simpler viral infections.

Testing might also be recommended if you have unexplained fatigue or illness that could be related to EBV, particularly if other common causes have been ruled out. Some people develop prolonged symptoms following EBV infection, and testing can help confirm whether EBV was the cause.

Who Should Be Tested for EBV Antibodies

EBV antibody testing is most commonly recommended when you have symptoms that could indicate glandular fever or infectious mononucleosis. A GP may order a blood test to confirm if you have glandular fever and to rule out other illnesses alongside other symptoms.

The classic symptoms that might prompt EBV testing include persistent fatigue, fever, sore throat, swollen lymph nodes, and sometimes an enlarged spleen. Symptoms include tiredness, fever, sore throat, swollen lymph nodes, an enlarged spleen and sometimes an enlarged liver. These symptoms can last for weeks or months, distinguishing glandular fever from simpler viral infections.

Testing might also be recommended if you have unexplained fatigue or illness that could be related to EBV, particularly if other common causes have been ruled out. Some people develop prolonged symptoms following EBV infection, and testing can help confirm whether EBV was the cause.

Who Should Be Tested for EBV Antibodies

EBV antibody testing is most commonly recommended when you have symptoms that could indicate glandular fever or infectious mononucleosis. A GP may order a blood test to confirm if you have glandular fever and to rule out other illnesses alongside other symptoms.

The classic symptoms that might prompt EBV testing include persistent fatigue, fever, sore throat, swollen lymph nodes, and sometimes an enlarged spleen. Symptoms include tiredness, fever, sore throat, swollen lymph nodes, an enlarged spleen and sometimes an enlarged liver. These symptoms can last for weeks or months, distinguishing glandular fever from simpler viral infections.

Testing might also be recommended if you have unexplained fatigue or illness that could be related to EBV, particularly if other common causes have been ruled out. Some people develop prolonged symptoms following EBV infection, and testing can help confirm whether EBV was the cause.

Get started

Understanding Your Results

Interpreting EBV antibody results requires understanding the combination of different antibody types rather than looking at individual results in isolation. The pattern tells the complete story of your EBV status.

If all antibody tests are negative, it typically means you haven't been exposed to EBV and remain susceptible to infection. If an individual is asymptomatic and negative for VCA-IgG, then that person has likely not been previously exposed to EBV and is vulnerable to infection.

A pattern showing positive VCA IgM and VCA IgG with negative EBNA IgG suggests current or very recent EBV infection. This is the typical pattern seen in acute glandular fever. Your doctor will likely focus on symptom management and monitoring your recovery.

When VCA IgG and EBNA IgG are both positive but VCA IgM is negative, it indicates past EBV infection. If the VCA-IgM is negative but VCA-IgG and an EBNA antibody are positive, then it is likely that the person tested had a previous EBV infection. This is the most common pattern in healthy adults and doesn't require treatment.

Occasionally, you might see VCA IgG positive with both VCA IgM and EBNA IgG negative. This less common pattern can indicate either very early infection (before EBNA antibodies develop) or a small percentage of people who don't develop EBNA antibodies after infection.

Here is a table to help simplify this relationship:

VCA‑IgM	VCA‑IgG	EBNA‑IgG	Pattern / Interpretation
Negative	Negative	Negative	No prior exposure — susceptible
Positive	Positive	Negative	Acute / very recent EBV infection
Negative	Positive	Positive	Past (remote) EBV infection — immune
Negative	Positive	Negative	Early infection or EBNA delayed / non‑seroconversion

Understanding Your Results

Interpreting EBV antibody results requires understanding the combination of different antibody types rather than looking at individual results in isolation. The pattern tells the complete story of your EBV status.

If all antibody tests are negative, it typically means you haven't been exposed to EBV and remain susceptible to infection. If an individual is asymptomatic and negative for VCA-IgG, then that person has likely not been previously exposed to EBV and is vulnerable to infection.

A pattern showing positive VCA IgM and VCA IgG with negative EBNA IgG suggests current or very recent EBV infection. This is the typical pattern seen in acute glandular fever. Your doctor will likely focus on symptom management and monitoring your recovery.

When VCA IgG and EBNA IgG are both positive but VCA IgM is negative, it indicates past EBV infection. If the VCA-IgM is negative but VCA-IgG and an EBNA antibody are positive, then it is likely that the person tested had a previous EBV infection. This is the most common pattern in healthy adults and doesn't require treatment.

Occasionally, you might see VCA IgG positive with both VCA IgM and EBNA IgG negative. This less common pattern can indicate either very early infection (before EBNA antibodies develop) or a small percentage of people who don't develop EBNA antibodies after infection.

Here is a table to help simplify this relationship:

VCA‑IgM	VCA‑IgG	EBNA‑IgG	Pattern / Interpretation
Negative	Negative	Negative	No prior exposure — susceptible
Positive	Positive	Negative	Acute / very recent EBV infection
Negative	Positive	Positive	Past (remote) EBV infection — immune
Negative	Positive	Negative	Early infection or EBNA delayed / non‑seroconversion

Understanding Your Results

Interpreting EBV antibody results requires understanding the combination of different antibody types rather than looking at individual results in isolation. The pattern tells the complete story of your EBV status.

If all antibody tests are negative, it typically means you haven't been exposed to EBV and remain susceptible to infection. If an individual is asymptomatic and negative for VCA-IgG, then that person has likely not been previously exposed to EBV and is vulnerable to infection.

A pattern showing positive VCA IgM and VCA IgG with negative EBNA IgG suggests current or very recent EBV infection. This is the typical pattern seen in acute glandular fever. Your doctor will likely focus on symptom management and monitoring your recovery.

When VCA IgG and EBNA IgG are both positive but VCA IgM is negative, it indicates past EBV infection. If the VCA-IgM is negative but VCA-IgG and an EBNA antibody are positive, then it is likely that the person tested had a previous EBV infection. This is the most common pattern in healthy adults and doesn't require treatment.

Occasionally, you might see VCA IgG positive with both VCA IgM and EBNA IgG negative. This less common pattern can indicate either very early infection (before EBNA antibodies develop) or a small percentage of people who don't develop EBNA antibodies after infection.

Here is a table to help simplify this relationship:

VCA‑IgM	VCA‑IgG	EBNA‑IgG	Pattern / Interpretation
Negative	Negative	Negative	No prior exposure — susceptible
Positive	Positive	Negative	Acute / very recent EBV infection
Negative	Positive	Positive	Past (remote) EBV infection — immune
Negative	Positive	Negative	Early infection or EBNA delayed / non‑seroconversion

Understanding Your Results

Interpreting EBV antibody results requires understanding the combination of different antibody types rather than looking at individual results in isolation. The pattern tells the complete story of your EBV status.

If all antibody tests are negative, it typically means you haven't been exposed to EBV and remain susceptible to infection. If an individual is asymptomatic and negative for VCA-IgG, then that person has likely not been previously exposed to EBV and is vulnerable to infection.

A pattern showing positive VCA IgM and VCA IgG with negative EBNA IgG suggests current or very recent EBV infection. This is the typical pattern seen in acute glandular fever. Your doctor will likely focus on symptom management and monitoring your recovery.

When VCA IgG and EBNA IgG are both positive but VCA IgM is negative, it indicates past EBV infection. If the VCA-IgM is negative but VCA-IgG and an EBNA antibody are positive, then it is likely that the person tested had a previous EBV infection. This is the most common pattern in healthy adults and doesn't require treatment.

Occasionally, you might see VCA IgG positive with both VCA IgM and EBNA IgG negative. This less common pattern can indicate either very early infection (before EBNA antibodies develop) or a small percentage of people who don't develop EBNA antibodies after infection.

Here is a table to help simplify this relationship:

VCA‑IgM	VCA‑IgG	EBNA‑IgG	Pattern / Interpretation
Negative	Negative	Negative	No prior exposure — susceptible
Positive	Positive	Negative	Acute / very recent EBV infection
Negative	Positive	Positive	Past (remote) EBV infection — immune
Negative	Positive	Negative	Early infection or EBNA delayed / non‑seroconversion

The Takeaway

EBV antibody testing provides valuable insights into your history with one of the world's most common viruses. The different antibodies work together like pieces of a puzzle, revealing whether you're currently fighting the infection, recently recovered, or have long-standing immunity from past exposure.

Understanding your EBV antibody results helps explain current symptoms and guides decisions. While most EBV infections resolve naturally with rest and supportive care, knowing your infection status can provide peace of mind and help you make informed decisions about activity levels and recovery expectations.

The Takeaway

EBV antibody testing provides valuable insights into your history with one of the world's most common viruses. The different antibodies work together like pieces of a puzzle, revealing whether you're currently fighting the infection, recently recovered, or have long-standing immunity from past exposure.

Understanding your EBV antibody results helps explain current symptoms and guides decisions. While most EBV infections resolve naturally with rest and supportive care, knowing your infection status can provide peace of mind and help you make informed decisions about activity levels and recovery expectations.

The Takeaway

EBV antibody testing provides valuable insights into your history with one of the world's most common viruses. The different antibodies work together like pieces of a puzzle, revealing whether you're currently fighting the infection, recently recovered, or have long-standing immunity from past exposure.

Understanding your EBV antibody results helps explain current symptoms and guides decisions. While most EBV infections resolve naturally with rest and supportive care, knowing your infection status can provide peace of mind and help you make informed decisions about activity levels and recovery expectations.

The Takeaway

EBV antibody testing provides valuable insights into your history with one of the world's most common viruses. The different antibodies work together like pieces of a puzzle, revealing whether you're currently fighting the infection, recently recovered, or have long-standing immunity from past exposure.

Understanding your EBV antibody results helps explain current symptoms and guides decisions. While most EBV infections resolve naturally with rest and supportive care, knowing your infection status can provide peace of mind and help you make informed decisions about activity levels and recovery expectations.

References

NHS. (2024). Glandular fever. Available from: https://www.nhs.uk/conditions/glandular-fever/
Centers for Disease Control and Prevention. (2024). Laboratory Testing for Epstein-Barr Virus (EBV). Available from: https://www.cdc.gov/epstein-barr/php/laboratories/index.html
Lab Tests Online UK. (2024). Epstein-Barr Virus Antibodies. Available from: https://labtestsonline.org.uk/tests/epstein-barr-virus-antibodies
NHS Foundation Trust. (2025). EBV (glandular fever) antibodies (mononucleosis). Available from: https://www.gloshospitals.nhs.uk/our-services/services-we-offer/pathology/tests-and-investigations/ebv-glandular-fever-antibodies/
Hess RD. Routine Epstein-Barr Virus Diagnostics from the Laboratory Perspective. Clinical Microbiology Reviews. 2004;17(2):394-401.

References

NHS. (2024). Glandular fever. Available from: https://www.nhs.uk/conditions/glandular-fever/
Centers for Disease Control and Prevention. (2024). Laboratory Testing for Epstein-Barr Virus (EBV). Available from: https://www.cdc.gov/epstein-barr/php/laboratories/index.html
Lab Tests Online UK. (2024). Epstein-Barr Virus Antibodies. Available from: https://labtestsonline.org.uk/tests/epstein-barr-virus-antibodies
NHS Foundation Trust. (2025). EBV (glandular fever) antibodies (mononucleosis). Available from: https://www.gloshospitals.nhs.uk/our-services/services-we-offer/pathology/tests-and-investigations/ebv-glandular-fever-antibodies/
Hess RD. Routine Epstein-Barr Virus Diagnostics from the Laboratory Perspective. Clinical Microbiology Reviews. 2004;17(2):394-401.

References

NHS. (2024). Glandular fever. Available from: https://www.nhs.uk/conditions/glandular-fever/
Centers for Disease Control and Prevention. (2024). Laboratory Testing for Epstein-Barr Virus (EBV). Available from: https://www.cdc.gov/epstein-barr/php/laboratories/index.html
Lab Tests Online UK. (2024). Epstein-Barr Virus Antibodies. Available from: https://labtestsonline.org.uk/tests/epstein-barr-virus-antibodies
NHS Foundation Trust. (2025). EBV (glandular fever) antibodies (mononucleosis). Available from: https://www.gloshospitals.nhs.uk/our-services/services-we-offer/pathology/tests-and-investigations/ebv-glandular-fever-antibodies/
Hess RD. Routine Epstein-Barr Virus Diagnostics from the Laboratory Perspective. Clinical Microbiology Reviews. 2004;17(2):394-401.

References

NHS. (2024). Glandular fever. Available from: https://www.nhs.uk/conditions/glandular-fever/
Centers for Disease Control and Prevention. (2024). Laboratory Testing for Epstein-Barr Virus (EBV). Available from: https://www.cdc.gov/epstein-barr/php/laboratories/index.html
Lab Tests Online UK. (2024). Epstein-Barr Virus Antibodies. Available from: https://labtestsonline.org.uk/tests/epstein-barr-virus-antibodies
NHS Foundation Trust. (2025). EBV (glandular fever) antibodies (mononucleosis). Available from: https://www.gloshospitals.nhs.uk/our-services/services-we-offer/pathology/tests-and-investigations/ebv-glandular-fever-antibodies/
Hess RD. Routine Epstein-Barr Virus Diagnostics from the Laboratory Perspective. Clinical Microbiology Reviews. 2004;17(2):394-401.

EBV antibodies

EBV antibodies

EBV antibodies

EBV antibodies

EBV antibodies

EBV antibodies

EBV antibodies

EBV antibodies

EBV antibodies

EBV antibodies

EBV antibodies

Your Body's EBV Exposure Story

Your Body's EBV Exposure Story

Your Body's EBV Exposure Story

When EBV Antibodies Tell Different Stories

When EBV Antibodies Tell Different Stories

When EBV Antibodies Tell Different Stories

When EBV Antibodies Tell Different Stories

What Influences Your EBV Antibody Levels

What Influences Your EBV Antibody Levels

What Influences Your EBV Antibody Levels

What Influences Your EBV Antibody Levels

Who Should Be Tested for EBV Antibodies

Who Should Be Tested for EBV Antibodies

Who Should Be Tested for EBV Antibodies

Who Should Be Tested for EBV Antibodies

Understanding Your Results

Understanding Your Results

Understanding Your Results

Understanding Your Results

When EBV Antibodies Tell Different Stories

When EBV Antibodies Tell Different Stories

When EBV Antibodies Tell Different Stories

When EBV Antibodies Tell Different Stories

What Influences Your EBV Antibody Levels

What Influences Your EBV Antibody Levels

What Influences Your EBV Antibody Levels

What Influences Your EBV Antibody Levels

Who Should Be Tested for EBV Antibodies

Who Should Be Tested for EBV Antibodies

Who Should Be Tested for EBV Antibodies

Who Should Be Tested for EBV Antibodies

Understanding Your Results

Understanding Your Results

Understanding Your Results

Understanding Your Results

The Takeaway

The Takeaway

The Takeaway

The Takeaway

References

References

References

References

Research articles

Research articles

Research articles

Control your preventive health with Emerald